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SUMMARY – The 8-hydroxy-deoxyguanosine (8-OHdG) is one of the customary products of 
oxidized DNA. The purpose of this study was to compare salivary and plasma 8-OHdG concentra-
tions in a group of chronic periodontitis patients to those measured in a group of patients with healthy 
periodontium, as well as to determine the impact of periodontal therapy on 8-OHdG concentrations 
in saliva and plasma in chronic periodontitis patients. The study sample comprised of 24 patients with 
chronic periodontitis and 16 periodontally healthy individuals. Plaque index, gingival index, papilla 
bleeding index, probing depth and clinical attachment level were indices used to determine patient 
periodontal status. Salivary and plasma 8-OHdG concentrations were determined by ELISA method. 
The salivary 8-OHdG concentration was statistically significantly higher in the group of periodontitis 
patients compared to periodontally healthy subjects. After initial periodontal therapy, the 8-OHdG 
concentration in saliva was significantly reduced in the periodontitis group (p=0.021). Differences in 
plasma 8-OHdG concentrations between the two groups did not reach statistical significance and no 
significant changes were noted in the periodontitis group following initial periodontal therapy. A 
higher salivary 8-OHdG concentration reflects increased oxidative stress caused by periodontal dis-
ease. Initial periodontal therapy may be helpful in reducing salivary 8-OHdG concentrations in 
chronic periodontitis patients.
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Introduction
Periodontitis is an inflammatory disease that dam-
ages the tooth supporting structures and is one of the 
main causes of tooth loss in adults1. While periodontal 
pathogens are recognized as primary etiologic factors, 
excessive host response to bacterial challenge has a de-
cisive role in the disease development2-4. Growing body 
of empirical evidence indicates that periodontitis in-
duces excessive reactive oxygen species (ROS) produc-
tion in periodontal tissue5-7. Additionally, some au-
thors speculate that, during phagocytosis of periodon-
tal pathogens, polymorphonuclear leukocytes also 
produce ROS, which can exacerbate oxidative stress 
caused by periodontitis8.
On the other hand, findings yielded by several 
studies suggest that periodontal infection can adverse-
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ly affect systemic health, leading to coronary heart dis-
ease, atherosclerosis, diabetes mellitus, preterm labor, 
low birth weight delivery, and respiratory diseases9-12. 
Although the processes of periodontal diseases that 
are believed to increase the risk of developing these 
systemic diseases are complex and not fully under-
stood, some authors suggest that diffusion of ROS 
produced by periodontal inflammation into the blood-
stream is the contributing factor. Once in the blood-
stream, ROS may cause protein, lipid and nucleoside 
oxidation, resulting in systemic oxidative stress that 
can cause remote tissue and organ damage13,14.
One of the customary products of oxidized DNA is 
the 8-hydroxy-deoxyguanosine (8-OHdG). Findings 
yielded by several studies indicate that 8-OHdG may 
serve as an oxidative stress biomarker and can be em-
ployed in evaluating oxidative DNA damage resulting 
from a wide range of diseases such as diabetes mellitus, 
cancer, neurovegetative diseases, rheumatoid arthritis, 
coronary artery disease, and liver diseases15-20. More re-
cent research also suggests a link between 8-OHdG 
concentration and chronic periodontitis21-23.
Extant studies indicate that salivary 8-OHdG con-
centrations are significantly higher in chronic peri-
odontitis patients than in healthy individuals and that 
concentration of this marker tends to decrease follow-
ing periodontal treatment22-26. Similarly, it can be pos-
tulated that, if periodontitis causes blood oxidative 
stress, its levels would likely be reduced due to peri-
odontal treatment. However, data regarding the influ-
ence of oxidative stress arising from periodontal le-
sions on the 8-OHdG concentration in systemic cir-
culation currently are limited22,26,27. As the data regard-
ing the impact of treatment of periodontal diseases on 
the 8-OHdG concentrations in systemic circulation 
are particularly scarce, further investigation is war-
ranted.
The aim of the present study was to determine sali-
vary and plasma 8-OHdG concentrations in peri-
odontally healthy patients and those diagnosed with 
chronic periodontal diseases, as well as to compare 
salivary and plasma 8-OHdG concentrations mea-
sured before and after periodontitis therapy.
Subjects and Methods
Systemically healthy nonsmokers aged 25-70 years 
with more than 20 teeth present having received no 
periodontitis therapy in the past six months were in-
vited to take part in the study. The patients that re-
ported taking antibiotics or anti-inflammatory drugs 
in the last six months, as well as anti-oxidant or vita-
min supplement consumers were excluded from the 
study. Forty patients that met the study inclusion cri-
teria agreed to participate. Prior to commencing the 
study, approval was obtained from the local Ethics 
Committee and all participants provided a written in-
formed consent after verbal and written explanation 
regarding the nature of the study and treatment they 
would undergo. All procedures performed in the study 
involving human participants were in accordance with 
the Declaration of Helsinki.
Periodontal condition was evaluated through the 
following indices, measured at the mesial, buccal, distal 
and lingual surfaces of each tooth: plaque index (PI)28; 
gingival index (GI)29; papilla bleeding index (PBI)30; 
probing depth (PD); and clinical attachment level 
(CAL). Michigan ‘O’ probe with William’s markings 
was used for this purpose. Saliva and plasma 8-OHdG 
concentrations were measured to assess oxidative 
DNA damage.
Samples of unstimulated whole saliva (approxi-
mately 2 mL) were obtained from each participant in 
the morning, prior to any periodontal manipulation, 
whereby the participants were instructed not to con-
sume any food or drink for 8 hours prior to attending 
the appointment. All patients rinsed their mouth with 
water before expectorating saliva into a disposable 
tube. After centrifugation of collected samples at 3000 
g for 10 minutes in the laboratory, the supernatants 
were transferred to Eppendorf tubes and stored at -80 
°C until final analysis.
Blood samples were collected from the fingertip at 
chairside using tubes coated with EDTA (Kabe Labo-
technik, Germany) and transported to the laboratory, 
where they were immediately centrifuged at 3000 g for 
10 minutes, after which the plasma samples were 
transferred to Eppendorf tubes and stored at -80 °C 
until final analysis.
Salivary and plasma 8-OHdG concentrations were 
determined by ELISA (Cell Biolabs OxiSelectTM, 
USA) according to the manufacturer’s instructions. 
The kit has an 8-OHdG detection sensitivity range of 
100 pg/mL to 20 ng/mL. All samples were tested in 
duplicate. The results were expressed in ng/mL.
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Based on clinical measurements, two groups were 
formed, comprising of chronic periodontitis patients 
(CP) and subjects with healthy periodontium (H). The 
CP group included patients with at least one pocket 
with PD ≥5 mm and CAL ≥4 mm per quadrant, ac-
companied by positive bleeding on probing. Patients 
without clinical signs of periodontal diseases formed 
the control group (group H).
Patients in whom periodontal disease was diag-
nosed underwent initial therapy, which included in-
tensive hygiene phase, and scaling and root planing 
within seven days. Scaling and root planing were con-
ducted using periodontal curettes (Gracey Access cu-
rettes, Kohler, Austria) and ultrasonic scalers (Mini-
Piezon, EMS, Switzerland).
In chronic periodontitis patients, measurements of 
all periodontal indices were recorded, and saliva and 
blood sampling and analysis were performed at two 
time points, i.e. at the beginning of the study and three 
months after completing the initial treatment. In pa-
tients with healthy periodontium, measurements were 
taken and saliva and blood sampling and analysis were 
performed only once, at the beginning of the study.
In order to evaluate the particular influence of the 
GI, PD and CAL on the 8-OHdG levels, patients in 
the CP group were additionally subdivided as follows: 
based on the GI scores, the samples were allocated to 
the subgroups with moderate (Loë-Silness 0.1-2) or 
severe (Loë-Silness 2.1-3) inflammation; according to 
PD values, patients were allocated to the subgroups 
with PD ≥5 mm on more than 20% of sites or PD ≥5 
mm on less than 20% of sites; and according to CAL 
measurements, patients were allocated to the sub-
groups with CAL ≥3 mm or CAL <3 mm. 
Data collected as part of the study were analyzed 
using the SPSS 16 for Windows statistical package. 
All values were expressed as mean ± SD. The t test was 
used to analyze differences in clinical parameters, age, 
and salivary and plasma 8-OHdG concentrations be-
tween the groups. Wilcoxon test was utilized to deter-
mine differences in salivary and plasma 8-OHdG lev-
els measured before and after periodontal therapy, as 
well as for assessing the influence of GI, PD and CAL 
on the 8-OHdG concentrations before and after treat-
ment. Results were considered significant at p<0.05.
Results
The study sample comprised of 40 patients, 24 of 
them diagnosed with chronic periodontitis (8 male 
and 16 female, aged 30-70 years, mean age 49.30 
years), while the remaining 16 subjects were periodon-
tally healthy and served as controls (6 male and 10 fe-
male, aged 27-65 years, mean age 47.28 years). There 
were no statistically significant differences in age and 
gender composition of the two groups.
Table 1. Clinical parameters and 8-OHdG levels in saliva and plasma in the CP and H group at baseline and three 
months upon periodontal therapy completion
CP group (baseline) H group CP group (after therapy)
Mean±SD Min-max Mean±SD Min-max Mean±SD Min-max
PI 1.35±0.40 0.50-1.97 0.28±0.33a 0.04-0.78 0.29±0.10b 0.13-0.61
GI 1.66±0.50 1.15-2.79 0.22±0.39a 0.00-0.73 0.34±0.39b 0.00-1.22
PBI 1.41±0.59 0.64-3.07 0.20±0.26ac 0.00-0.58 0.62±0.33b 0.08-1.65
PD (mm) 3.22±0.51 2.57-4.42 1.30±0.29 ac 1.15-1.65 2.64±0.44b 1.95-3.81
CAL (mm) 2.63±1.07 1.76-5.50 0.35±0.62 ac 0.00-0.59 2.05±0.98b 0.59-4.08
8-OHdGs (ng/mL) 0.89±0.42 0.25-1.63 0.67±0.30d 0.18-1.03 0.68±0.31e 0.25-1.20
8-OHdGp (ng/mL) 0.49±0.18 0.17-0.81 0.44±0.23 0.11-1.00 0.44±0.15 0.20-0.78
CP = chronic periodontitis; H = healthy; SD = standard deviation; PI = plaque index; GI = gingival index; PBI = papilla bleeding index; 
PD = probing depth; CAL = clinical attachment level; 8-OHdGs = 8-hydroxy-deoxyguanosine in saliva; 8-OHdGp = 8-hydroxy-deoxy-
guanosine in plasma;
astatistically significant difference between CP group and H group at baseline (p<0.001);
bstatistically significant difference in CP group relative to baseline (p<0.001);
cstatistically significant difference between CP group and H group three months upon therapy completion (p<0.05);
dstatistically significant difference between CP and H group at baseline (p<0.05);
estatistically significant difference in the CP group compared to baseline values (p<0.05).
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Clinical periodontal measurements pertaining to 
the two groups at the beginning of the study and after 
periodontal disease therapy are presented in Table 1. 
At the beginning of the study, all periodontal indices 
were significantly higher in patients with chronic peri-
odontitis compared to healthy controls (p<0.001). 
Three months after initial therapy, significant reduc-
tion in PI, GI, PBI, PD and CAL was noted in the CP 
group (p<0.001).
The mean 8-OHdG concentrations in saliva and 
plasma are also shown in Table 1. In the CP group, 
8-OHdG concentrations in saliva were significantly 
higher compared to controls (p=0.024). Salivary con-
centrations of this marker decreased significantly after 
periodontal therapy (p=0.021). However, 8-OHdG 
concentrations in plasma were not significantly higher 
in the CP group compared to the healthy group 
(p=0.362). In addition, reduction in plasma 8-OHdG 
concentrations recorded upon completion of periodon-
tal treatment was not statistically significant (p=0.147).
Our results further indicated that salivary 8-OHdG 
concentration in the subgroup with PD ≥5 mm ≥20% 
Table 2. Influence of gingival inflammation on 8-OHdG levels in patients with periodontitis  
at baseline and three months upon periodontal therapy completion
8-OHdG
(ng/mL)




CP group (after therapy)
Mean±SD Min-max










CP = chronic periodontitis; 8-OHdG = 8-hydroxy-deoxyguanosine; SD = standard deviation;
astatistically significant difference compared with baseline in CP group (p<0.05).
Table 3. Influence of probing depth on 8-OHdG levels in patients with periodontitis at baseline  





CP group (after therapy)
Mean±SD Min-max










CP = chronic periodontitis; 8-OHdG = 8-hydroxy-deoxyguanosine; SD = standard deviation;
astatistically significant difference between ≥5 mm ≥20% and ≥5 mm <20% groups at baseline (p<0.05);
bstatistically significant difference in CP group relative to baseline values (p<0.05).
Table 4. Influence of clinical attachment level on 8-OHdG levels in patients with periodontitis  
at baseline and three months upon periodontal therapy completion
8-OHdG
(ng/mL) Clinical attachment level
CP group (baseline)
Mean±SD Min-max
CP group (after therapy)
Mean±SD Min-max










CP = chronic periodontitis; 8-OHdG = 8-hydroxy-deoxyguanosine; SD = standard deviation;
astatistically significant difference between CAL ≥3 mm and CAL <3 mm groups at baseline (p<0.05);
bstatistically significant difference in CP group compared to baseline values (p<0.05).
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was significantly higher compared to the subgroup 
with PD ≥5 mm <20%. Similarly, 8-OHdG concen-
tration in saliva was significantly higher in patients 
with CAL ≥3 mm than in the subgroup with CAL <3 
mm. However, differences in 8-OHdG concentrations 
in saliva between patients with severe and moderate 
gingival inflammation were not statistically significant. 
Additionally, plasma 8-OHdG concentrations were 
similar in the subgroups with severe and moderate 
gingival inflammation. No statistically significant dif-
ferences in plasma 8-OHdG concentration were re-
corded between the subgroup with PD ≥5 mm ≥20% 
and subgroup with PD ≥5 mm <20%, or between pa-
tients with CAL ≥3 mm and CAL <3 mm (Tables 2, 3 
and 4).
Discussion
Data reported in the majority of published studies 
on oxidative DNA damage reveal elevated salivary 
8-OHdG concentrations in chronic periodontitis pa-
tients24,31,32. These findings imply that the extent of 
oxidative burst in periodontitis may cause significant 
local DNA damage. In a study conducted by Canakci 
et al.33, salivary 8-OHdG concentration in patients 
with periodontitis was much higher than in the peri-
odontally healthy group (4.24 ng/mL and 1.26 ng/
mL, respectively). Sezer et al.34 also report 3.13 ng/mL 
and 1.56 ng/mL as 8-OHdG concentrations in saliva 
of periodontitis patients and healthy controls, respec-
tively. Our results are in line with these findings, as 
salivary 8-OHdG concentrations in the chronic peri-
odontitis group (0.89 ng/mL) were significantly high-
er than in the healthy group of patients (0.67 ng/mL). 
Our results are also in agreement with the approxi-
mate values of 8-OHdG reported by Dede et al.21. Dif-
ferences in methodology are likely the reason for such 
a marked discrepancy in salivary 8-OHdG concentra-
tions obtained in various studies. While we used whole 
unstimulated saliva as did Dede et al.21, Canakci et al.33 
and Sezer et al.34 utilized stimulated saliva. In fact, 
there is presently no consensus on whether oral envi-
ronment is better represented by stimulated or unstim-
ulated saliva, even though this may influence the 
8-OHdG levels measured. Periodontal status of the 
patients included in different studies could also be a 
source of differences in reported findings. This asser-
tion is grounded in the research conducted by Takane 
et al.,24,32 who reported significantly higher 8-OHdG 
concentrations in saliva of patients who had teeth with 
poor prognosis compared to patients with no such 
teeth or with healthy periodontium. These findings 
thus suggest that increased salivary 8-OHdG levels 
have a strong relationship with the severity of peri-
odontitis and can potentially serve as an indicator of 
disease progression.
In this study, we also evaluated the particular influ-
ence of GI, PD and CAL on the salivary 8-OHdG 
levels. Previous studies have shown that salivary 
8-OHdG concentrations are directly associated with 
periodontitis severity25,32,35,36. Ibrahem35, for example, 
reports on significantly higher 8-OHdG concentra-
tions in saliva of patients with PD >6 mm compared to 
those with PD <6 mm. We found that patients with 
PD ≥5 mm on more than 20% of sites also had sig-
nificantly higher salivary 8-OHdG concentrations 
compared to those measured in the group with PD ≥5 
mm on less than 20% of sites. Additionally, our study 
showed that 8-OHdG concentration in the subgroup 
of patients with CAL ≥ 3 mm was significantly higher 
compared to that obtained for the subgroup of patients 
with CAL < 3 mm. On the other hand, it seems that 
the GI level did not exacerbate DNA damage, since 
we found no significant differences between 8-OHdG 
concentrations in saliva of patients with severe and 
moderate gingival inflammation. These results are in 
line with those reported by Sezer et al.34 and Canakci 
et al.,33 who noted that 8-OHdG levels in saliva are 
significantly positively correlated with PD and CAL, 
but not with GI and PI. Thus, it can be assumed that 
inflammation alone does not lead to significant eleva-
tion of salivary 8-OHdG concentration.
Several studies have shown that salivary 8-OHdG 
concentrations can decrease after periodontal therapy 
relative to the baseline35,37. Ibrahem35 reports on a sig-
nificant reduction in salivary 8-OHdG concentrations 
in patients with periodontal pockets >6 mm, but not in 
patients with periodontal pockets <6 mm. In our study, 
periodontal therapy also led to reduction in 8-OHdG. 
Decrease in 8-OHdG concentrations that was 
achieved in patients with PD ≥5 mm at more than 
20% of sites was twice as high as that in patients with 
PD ≥5 mm at less than 20% of sites. Hence, it can be 
concluded that initial periodontal therapy including 
mechanical debridement and removal of periodontal 
pathogens can result in reduction of oxidative stress in 
the oral cavity.
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In our study, plasma 8-OHdG concentrations were 
measured in patients with CP, as well as in subjects 
with healthy periodontium, with the aim of ascertain-
ing whether periodontal tissue damage affects circulat-
ing oxidative stress. Ekuni et al.7 studied a rat peri-
odontitis model and report higher gingival and plasma 
8-OHdG levels relative to controls. The authors con-
clude that 8-OHdG reflects periodontal health status 
and serves as a clinical biomarker of oxidative damage 
in periodontitis. They further indicated that, as cyto-
kines are commonly used as systemic markers of in-
flammation in periodontitis, it may be clinically useful 
to detect the 8-OHdG level in addition to the cyto-
kine levels. In the studies on humans, Hendek et al.22 
and Onder et al.26 found significant differences in sali-
vary 8-OHdG levels between periodontitis patients 
and periodontally healthy group, but not for 8-OHdG 
in serum. In the present study, we found that the peri-
odontitis and control groups had similar 8-OHdG 
concentrations in plasma. Even though the subgroup 
with CAL ≥3 mm had higher 8-OHdG concentra-
tions in plasma compared to that with CAL <3 mm, 
the difference was not statistically significant.
Ekuni et al. also report that mechanical stimulation 
through tooth brushing reduced 8-OHdG levels in 
plasma in an animal periodontitis model7. The authors 
conclude that reduction in gingival inflammation due 
to tooth brushing may decrease ROS production and 
limit transfer of oxidative stress from periodontal le-
sions to systemic circulation. Our results, however, did 
not support this conclusion, as no significant differ-
ences were noted in the 8-OHdG concentrations in 
plasma before and after periodontal treatment.
The potential limitations of this study could be a 
relatively small sample of patients and the fact that we 
used only one marker of oxidative stress. Therefore, 
further research is required in order to reach more de-
finitive conclusions about the impact of periodontal 
disease on systemic oxidative stress.
Within the limitations of the present study, our re-
sults suggest that 8-OHdG, a product of DNA oxida-
tion, was elevated in the saliva of CP patients. The level 
of salivary 8-OHdG could be associated with periodon-
tal disease severity. The results yielded by our study also 
showed that periodontal therapy was beneficial in re-
ducing oxidative stress, as it resulted in lower salivary 
8-OHdG concentrations. There was no elevation in 
plasma 8-OHdG concentrations in CP patients.
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Sažetak
UTJECAJ PARODONTNE TERAPIJE NA KONCENTRACIJU 8-HIDROKSI-DEOKSIGVANOZINA  
U SLINI I PLAZMI KOD BOLESNIKA S KRONIČNIM PARODONTITISOM
T. Veljović, M. Đurić, I. Gušić, J. Mirnić, S. Čakić, A. Maletin i S. Brkić
8-hidroksi-deoksigvanozin (8-OHdG) je jedan od uobičajenih proizvoda oksidirane DNA. Svrha ove studije bila je 
 usporediti koncentracije 8-OHdG u slini i plazmi u skupini pacijenata s kroničnim parodontitisom i skupini ispitanika sa 
zdravim parodontom te odrediti utjecaj parodontne terapije na koncentracije 8-OHdG u slini i plazmi kod pacijenata s 
kroničnim parodontitisom. Uzorak studije činila su 24 pacijenta s kroničnim parodontitisom i 16 osoba sa zdravim parodon-
tom. Indeks plaka, indeks gingive, indeks krvarenja iz papile, dubina sondiranja i razina kliničkoga pričvrstka bili su indeksi 
koji su primijenjeni za određivanje parodontnog stanja pacijenata. Koncentracije 8-OHdG u slini i plazmi određivane su 
metodom ELISA. Koncentracija 8-OHdG u slini bila je statistički značajno veća u skupini pacijenata s parodontitisom u 
usporedbi s ispitanicima sa zdravim parodontom. Nakon inicijalne parodontalne terapije, koncentracija 8-OHdG u slini 
značajno je smanjena u skupini pacijenata s parodontitisom (p=0,021). Razlike u koncentracijama 8-OHdG u plazmi izme-
đu dviju skupina nisu dostigle statističku značajnost i nisu uočene značajne promjene u skupini pacijenata s parodontitisom 
nakon inicijalne parodontalne terapije. Veća koncentracija 8-OHdG u slini odražava povećani oksidacijski stres uzrokovan 
parodontnom bolešću. Inicijalna parodontna terapija može biti korisna u smanjenju koncentracije 8-OHdG u pacijenata s 
kroničnim parodontitisom.
Ključne riječi: Deoksi gvanozin; Oksidacijski stres; Parodontna bolest; Slina; Plazma
